ArticleTranslational cancer research2019

Pembrolizumab monotherapy in advanced NSCLC patients with low PD-L1 expression: is there real evidence?

Alfonso Fiorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.